Prevention & lipidsMeta-analysis

Sex differences in treatment of familial hypercholesterolaemia: a meta-analysis

Eur Heart JPublished

  • Systematic review and meta-analysis

Authors' conclusion

Females with FH were less likely to be treated intensively and to reach guideline-recommended LDL-C targets.

Study context

Population
Adults with familial hypercholesterolaemia (FH)133 publications
Comparison
Females vs males with FH
Outcome
Sex-related disparities in treatment, response and LDL-C target achievement

Pooled result

As reported in the abstract

OR

on lipid-lowering therapy; 25 observational studies, 129 441 participants
.74 (95% CI .66-.85)
reaching LDL-C < 2.5 mmol/L
.85 (95% CI .74-.97)

Further pooled results

Response to fixed doses of lipid-lowering therapy (16 interventional trials, 1840 participants)

No differences between males and females in response

MACE incl. MI, atherosclerotic CVD and CV mortality

Male sex associated with two-fold greater relative risk

Original publication

Sex differences in treatment of familial hypercholesterolaemia: a meta-analysis. Eur Heart J. Published 8 July 2024. doi:10.1093/eurheartj/ehae417

Summarised from the published abstract; every number is checked against it